Home›Companies›Biotech & Pharma›Ordaos

Ordaos, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 1, 2025·Suggest an edit

About Ordaos

Ordaos is a private company based in New York, New York. It has reported $16,817,123 raised in six offerings on Form D since June 2022. Its chief executive is David Longo.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 13, 2025Apr 1, 2025$337,705of $2.0M target3$112KEquityRule 506(b)Form D ↗
Aug 29, 2024Sep 11, 2024$3,104,999of $4.0M target5$620KEquityRule 506(b)Form D ↗
Dec 22, 2023Dec 29, 2023$500,000fully sold2$250KDebt, Options, Convertible Debt with WarrantsRule 506(b)Form D ↗
Dec 14, 2023Dec 28, 2023$332,000of $1.7M target4$83,000Debt, Options, Convertible DebtRule 506(b)Form D ↗
Mar 8, 2023Nov 3, 2023$1,800,000of $5.0M target4$450KDebt, Convertible debtRule 506(b)Form D ↗
Jun 2, 2022Jun 15, 2022$10,742,419fully sold10$1.0MEquityRule 506(b)Form D ↗
Total, six offerings$16,817,123

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ordaos's Form D filed Apr 1, 2025.

UP
Ulo Palm
Director
DL
David Longo
Chief Executive Officer and director
BB
JR
James Ramey
Director

Earlier filings also listed Scott Horner (director, last listed Jun 2022).

Sources

  1. SECOrdaos, Inc. filing history